Search research articles
Contact Us
Filters
Showing results (11-20 of 201) with videos related to
Page
of 21
Sort By:
Psychopharmacology
|
January 1, 1988
Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats
R J Mandel, L J Thal
Brain Research
|
January 22, 1993
Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons
A J Dekker, L J Thal
Life Sciences
|
January 1, 1996
Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin
J J Waite, L J Thal
Neuroscience
|
March 18, 2004
Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery
D P Pizzo, L J Thal
Neuroscience Research
|
January 1, 1995
The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis
J J Waite, L J Thal
Brain Research
|
July 3, 1992
Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements
A J Dekker, L J Thal
Physiology & Behavior
|
October 1, 1989
Nucleus basalis magnocellularis lesions facilitate two-way active avoidance
C P Dokla, L J Thal
Neurology
|
February 1, 1986
Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam
L J Thal, M Grundman, R Golden
International Clinical Psychopharmacology
|
February 25, 2003
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
Stuart A Montgomery, L J Thal, R Amrein
Journal of the American Geriatrics Society
|
September 1, 1991
Monitoring progression in Alzheimer's disease
D Galasko, J Corey-Bloom, L J Thal
Page
of 21
Search research articles
Search
Showing results (11-20 of 201) with videos related to
Sort By:
Page
of 21
Psychopharmacology
|
January 1, 1988
Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats
R J Mandel, L J Thal
Brain Research
|
January 22, 1993
Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons
A J Dekker, L J Thal
Life Sciences
|
January 1, 1996
Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin
J J Waite, L J Thal
Neuroscience
|
March 18, 2004
Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery
D P Pizzo, L J Thal
Neuroscience Research
|
January 1, 1995
The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis
J J Waite, L J Thal
Brain Research
|
July 3, 1992
Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements
A J Dekker, L J Thal
Physiology & Behavior
|
October 1, 1989
Nucleus basalis magnocellularis lesions facilitate two-way active avoidance
C P Dokla, L J Thal
Neurology
|
February 1, 1986
Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam
L J Thal, M Grundman, R Golden
International Clinical Psychopharmacology
|
February 25, 2003
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
Stuart A Montgomery, L J Thal, R Amrein
Journal of the American Geriatrics Society
|
September 1, 1991
Monitoring progression in Alzheimer's disease
D Galasko, J Corey-Bloom, L J Thal
Page
of 21